Back to Top
Brayton Purcell LLP
Call for A Free Consultation
800-598-0314
Nationwide Service for over 30 years

November 2004 Archives

Bextra® Linked to Heart Problems

FDA Panel To Meet in 2005 to Consider Risks of COX-2 Painkillers Related to Vioxx® WASHINGTON, DC -- November 19, 2004 -- Criticized for not recalling the arthritis drug Vioxx® years ago, the Food and Drug Administration will meet early in 2005 to discuss the safety of similar pain medicines...

Brayton Recognized for Work on Major Asbestos Case

Alan Brayton Named Finalist for Consumer Attorney of the Year SAN FRANCISCO, CA -- November 16, 2004 -- The Consumer Attorneys of California recognized Novato lawyer Alan Brayton as a finalist for the Consumer Attorney of the Year award at the group's annual awards dinner in San Francisco last Saturday....

Bextra® Use Associated with Stevens-Johnson Syndrome

FDA Likely to Put Warning on Arthritis Drug Bextra® WASHINGTON, DC -- November 12, 2004 -- The Food and Drug Administration (FDA) may add a "black box" alert to the insert for the arthritis drug, Bextra®, warning that the medicine can cause a severe allergic skin reaction known as Stevens-Johnson...

Vioxx Side Effects Include Heart Attacks and Strokes

Vioxx Side Effects Were Apparent Years Before The Drug Was Pulled Off the Market, Study Says November 12, 2004 -- The arthritis drug Vioxx (rofecoxib) should have been withdrawn at least four years prior to September 2004, when it was finally pulled off the shelves, a new study concludes. Published...

Vioxx Increases Risk of Heart Attacks and Strokes

Merck Knew About Vioxx Risks Early On, News Report Suggests WHITEHOUSE STATION, NJ -- November 5, 2004 -- Merck, the manufacturer of the popular arthritis medicine, Vioxx, knew that the drug caused heart problems long before it was pulled from the market in September, a new report by the Wall...